The purpose of this survey is to gain insight from patients who currently take Copaxone or who once took Copaxone to treat MS.
BioNews Services frequently launches surveys to help better understand those within our rare disease communities. Multiple Sclerosis News Today is dedicated to providing relevant content to the MS community.
This short survey will take approximately 3 minutes. It is currently only available for US members/users.
Tried to take survey but it says I’m not ‘authorized’ – which is pretty galling as I’m one of this sites moderators.
Hell I’m a ‘Keymaster’. So I also qualify as a senior baddie in the ‘Ghostbusters’ franchise!
Was on Copaxone very briefly. Had just failed with Rebif and went onto it as a holding option. It was even worse. Stopped me from walking completely. I figured I might as well have a better quality of life whilst I could. I unilaterally quit!
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.